Literature DB >> 20185379

Echocardiographic assessment of left ventricular geometry and the mitral valve apparatus in cats with hypertrophic cardiomyopathy.

Karsten Schober1, Amanda Todd.   

Abstract

OBJECTIVES: This retrospective study addressed the general hypothesis that abnormalities of the mitral valve apparatus are common in cats with idiopathic hypertrophic cardiomyopathy (HCM) and contribute to dynamic obstruction of the left ventricular outflow tract (LVOT). ANIMALS,
MATERIALS AND METHODS: 106 cats (28 controls and 78 with HCM) had transthoracic two-dimensional and Doppler echocardiography performed with quantification of 33 variables. Three groups of cats (control [Group-1], HCM without obstruction [Group-2], and HCM with obstruction [Group-3]) were identified and compared by analysis of variance, chi(2) analysis, and correlation analysis.
RESULTS: Cats in Group-3 had more LV and papillary muscle hypertrophy, increased length of the anterior mitral valve leaflet, and a higher prevalence of false tendons in the LVOT compared to cats in Group-2 (P < or = 0.05). The length of the anterior mitral valve leaflet was correlated to the severity of dynamic obstruction (P < or = 0.05) and the magnitude of LV hypertrophy (P < or = 0.001). Systolic anterior motion of chordae tendineae (CAM) was observed in 16% of control cats and >50% of cats with HCM (P < or = 0.05).
CONCLUSIONS: Abnormalities of the mitral valve are common in cats with HCM suggesting a possible role in the pathogenesis of dynamic outflow tract obstruction. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20185379     DOI: 10.1016/j.jvc.2009.09.004

Source DB:  PubMed          Journal:  J Vet Cardiol        ISSN: 1760-2734            Impact factor:   1.701


  12 in total

1.  Myosin-binding protein C DNA variants in domestic cats (A31P, A74T, R820W) and their association with hypertrophic cardiomyopathy.

Authors:  M Longeri; P Ferrari; P Knafelz; A Mezzelani; A Marabotti; L Milanesi; G Pertica; M Polli; P G Brambilla; M Kittleson; L A Lyons; F Porciello
Journal:  J Vet Intern Med       Date:  2013-01-17       Impact factor: 3.333

2.  Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus.

Authors:  R Langhorn; I N Kieler; J Koch; L B Christiansen; L R Jessen
Journal:  J Vet Intern Med       Date:  2017-12-12       Impact factor: 3.333

3.  Transient Myocardial Thickening in Cats Associated with Heart Failure.

Authors:  J Novo Matos; N Pereira; T Glaus; L Wilkie; K Borgeat; J Loureiro; J Silva; V Law; A Kranjc; D J Connolly; V Luis Fuentes
Journal:  J Vet Intern Med       Date:  2017-12-15       Impact factor: 3.333

4.  Clinical, epidemiological and echocardiographic features and prognostic factors in cats with restrictive cardiomyopathy: A retrospective study of 92 cases (2001-2015).

Authors:  Valérie Chetboul; Peggy Passavin; Emilie Trehiou-Sechi; Vassiliki Gouni; Camille Poissonnier; Jean-Louis Pouchelon; Loic Desquilbet
Journal:  J Vet Intern Med       Date:  2019-03-28       Impact factor: 3.333

5.  Biomarker changes with systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy.

Authors:  Joonbum Seo; Jessie Rosie Payne; Jose Novo Matos; Wesley Wynne Fong; David J Connolly; Virginia Luis Fuentes
Journal:  J Vet Intern Med       Date:  2020-08-21       Impact factor: 3.333

6.  Cardiovascular effects of dietary salt intake in aged healthy cats: a 2-year prospective randomized, blinded, and controlled study.

Authors:  Valérie Chetboul; Brice Stéphane Reynolds; Emilie Trehiou-Sechi; Patrick Nguyen; Didier Concordet; Carolina Carlos Sampedrano; Isabelle Testault; Jonathan Elliott; Jérôme Abadie; Vincent Biourge; Hervé Pierre Lefebvre
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

7.  Concurrent diseases and conditions in cats with renal infarcts.

Authors:  M C Hickey; K Jandrey; K S Farrell; D Carlson-Bremer
Journal:  J Vet Intern Med       Date:  2014-02-16       Impact factor: 3.333

8.  ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats.

Authors:  Virginia Luis Fuentes; Jonathan Abbott; Valérie Chetboul; Etienne Côté; Philip R Fox; Jens Häggström; Mark D Kittleson; Karsten Schober; Joshua A Stern
Journal:  J Vet Intern Med       Date:  2020-04-03       Impact factor: 3.333

9.  Retrospective evaluation of the safety and tolerability of pimobendan in cats with obstructive vs nonobstructive cardiomyopathy.

Authors:  Jessica L Ward; Efrem Z Kussin; Melissa A Tropf; Sandra P Tou; Teresa C DeFrancesco; Bruce W Keene
Journal:  J Vet Intern Med       Date:  2020-10-07       Impact factor: 3.333

10.  Tolerance of torasemide in cats with congestive heart failure: a retrospective study on 21 cases (2016-2019).

Authors:  Camille Poissonnier; Sarra Ghazal; Peggy Passavin; Maria-Paz Alvarado; Solène Lefort; Emilie Trehiou-Sechi; Vittorio Saponaro; Alix Barbarino; Julia Delle Cave; Charlie-Rose Marchal; Boris Depré; Etienne Vannucci; Renaud Tissier; Patrick Verwaerde; Valérie Chetboul
Journal:  BMC Vet Res       Date:  2020-09-16       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.